[144] PRECIGEN, INC. SEC Filing
Precigen, Inc. (PGEN) Form 144 notifies the market of a proposed sale of 252 common shares on Nasdaq with an aggregate market value of $970, against 297,972,920 shares outstanding. The filer reports acquiring 3,112,507 shares on 07/03/2018 in a public offering for cash.
The filing also discloses that Kapital Joe, LLC (Randal J. Kirk as agent) sold 1,403,360 common shares on 09/18/2025 for gross proceeds of $5,422,348. The signer certifies no undisclosed material adverse information and attests to the accuracy of the notice.
Precigen, Inc. (PGEN) Modulo 144 informa il mercato di una proposta di vendita di 252 azioni ordinarie su Nasdaq con un valore di mercato aggregato di $970, su una base di 297.972.920 azioni in circolazione. Il dichiarante riferisce di aver acquisito 3.112.507 azioni il 03/07/2018 in un'offerta pubblica in contanti.
La dichiarazione rivela inoltre che Kapital Joe, LLC (Randal J. Kirk come agente) ha venduto 1.403.360 azioni comuni il 18/09/2025 per un incasso lordo di $5.422.348. Il firmatario certifica che non esistono informazioni materiali avverse non divulgate e attesta l'accuratezza dell'avviso.
Precigen, Inc. (PGEN) Formulario 144 notifica al mercado una propuesta de venta de 252 acciones comunes en Nasdaq con un valor de mercado agregado de $970, frente a 297,972,920 acciones en circulación. El presentante informa haber adquirido 3,112,507 acciones el 03/07/2018 en una oferta pública en efectivo.
La presentación también revela que Kapital Joe, LLC (Randal J. Kirk como agente) vendió 1,403,360 acciones comunes el 18/09/2025 por ingresos brutos de $5,422,348. El firmante certifica que no existen informaciones materiales adversas no divulgadas y atestigua la precisión del aviso.
Precigen, Inc. (PGEN) 양식 144는 Nasdaq에서 252주 보통주의 제안 매도를 시장에 통지하며, 총 시장 가치가 $970이고 발행주식수 297,972,920주에 대응합니다. 제출자는 2018년 7월 3일에 현금 공모로 3,112,507주를 인수했다고 보고합니다.
또한 제출서는 Kapital Joe, LLC (래널드 J. 커크를 대리인으로)이 2025년 9월 18일에 보통주 1,403,360주를 매도하여 총 수익이 $5,422,348에 이른다고 공개합니다. 서명인은 공개되지 않은 중대한 악재 정보가 없으며 고지의 정확성을 선서합니다.
Precigen, Inc. (PGEN) Le Formulaire 144 informe le marché d'une proposition de vente de 252 actions ordinaires sur Nasdaq, d'une valeur marchande agrégée de $970, sur un total de 297 972 920 actions en circulation. Le déclarant indique avoir acquis 3 112 507 actions le 03/07/2018 lors d'une offre publique en espèces.
Le dossier révèle également que Kapital Joe, LLC (Randal J. Kirk comme agent) a vendu 1 403 360 actions ordinaires le 18/09/2025 pour un produit brut de $5 422 348. Le signataire certifie qu'il n'existe pas d'informations importantes non divulguées et atteste de l'exactitude de l'avis.
Precigen, Inc. (PGEN) Formular 144 benachrichtigt den Markt über einen geplanten Verkauf von 252 Stammaktien an der Nasdaq mit einem Gesamthandelswert von $970, gegenüber 297.972.920 ausstehenden Aktien. Der Einreicher meldet, am 03.07.2018 3.112.507 Aktien in einer Barofferte erworben zu haben.
Die Einreichung gibt außerdem bekannt, dass Kapital Joe, LLC (Randal J. Kirk als Bevollmächtigter) am 18.09.2025 1.403.360 Stammaktien verkauft hat und Bruttoerlöse von $5.422.348 erzielt wurden. Der Unterzeichner bestätigt, dass keine unbeachteten wesentlichen nachteiligen Informationen vorliegen und versichert die Richtigkeit des Hinweises.
Precigen, Inc. (PGEN) النموذج 144 يُنْبِئُ السوق بأيّ بيع مقترح لـ 252 سهمًا عاديًا على ناسداك بقيمة سوقية إجمالية تبلغ $970، مقارنة بـ 297,972,920 سهمًا قائمًا. يُبلِغ المُقدِّم عن امتلاكه 3,112,507 سهمًا بتاريخ 03/07/2018 في عرض عام نقدًا.
كما تكشف الوثيقة أن Kapital Joe, LLC (رامدل ج. كيرك وكيلًا) باع 1,403,360 سهمًا عاديًا في تاريخ 18/09/2025 بعوائد إجمالية قدرها $5,422,348. يؤكد المُوقِّع عدم وجود معلومات سلبية مادية غير معلنة ويشهد بدقة الإشعار.
Precigen, Inc. (PGEN) Form 144 通知市场有关在纳斯达克拟出售 252 股普通股,总市值为 $970,而流通股本为 297,972,920 股。申报人报告称在 2018/07/03 以现金公开发售方式取得了 3,112,507 股。
申报还披露 Kapital Joe, LLC (以 Randal J. Kirk 作为代理人) 于 2025/09/18 出售了 1,403,360 股普通股,毛收入为 $5,422,348。签署人证明没有未披露的重大不利信息,并证明通知的准确性。
- Disclosure compliance: Form 144 properly lists the class, acquisition details, and recent sales, supporting regulatory transparency
- Long-held shares: The securities to be sold trace to a 07/03/2018 public offering, showing acquisition provenance
- Recent affiliate sale: Kapital Joe, LLC sold 1,403,360 shares on 09/18/2025 for $5,422,348, indicating notable insider/affiliate liquidity
Insights
TL;DR: Routine Rule 144 notice; small proposed sale and a recent 1.4M-share disposition reported, reflecting insider/affiliate liquidity, not clearly material to valuation.
The filing records a proposed sale of 252 shares (aggregate value $970) under Rule 144 and documents a recent larger disposition by Kapital Joe, LLC of 1,403,360 shares for $5.42 million. For a company with ~298 million shares outstanding, the recent sale equals roughly 0.47% of the outstanding float, indicating insider/affiliate liquidity but not necessarily a material dilution event. The filing appears procedurally compliant and provides acquisition provenance dating to a 2018 public offering.
TL;DR: Disclosure is consistent with Rule 144 requirements; signer affirms no undisclosed material information.
The document follows Rule 144 format by identifying the class, intended sale amount, provenance of the shares, and recent sales by related parties. The signature statement affirms the absence of undisclosed material information, which is standard. The recent sale by a related entity is disclosed, enabling investor transparency about insider/affiliate transactions.
Precigen, Inc. (PGEN) Modulo 144 informa il mercato di una proposta di vendita di 252 azioni ordinarie su Nasdaq con un valore di mercato aggregato di $970, su una base di 297.972.920 azioni in circolazione. Il dichiarante riferisce di aver acquisito 3.112.507 azioni il 03/07/2018 in un'offerta pubblica in contanti.
La dichiarazione rivela inoltre che Kapital Joe, LLC (Randal J. Kirk come agente) ha venduto 1.403.360 azioni comuni il 18/09/2025 per un incasso lordo di $5.422.348. Il firmatario certifica che non esistono informazioni materiali avverse non divulgate e attesta l'accuratezza dell'avviso.
Precigen, Inc. (PGEN) Formulario 144 notifica al mercado una propuesta de venta de 252 acciones comunes en Nasdaq con un valor de mercado agregado de $970, frente a 297,972,920 acciones en circulación. El presentante informa haber adquirido 3,112,507 acciones el 03/07/2018 en una oferta pública en efectivo.
La presentación también revela que Kapital Joe, LLC (Randal J. Kirk como agente) vendió 1,403,360 acciones comunes el 18/09/2025 por ingresos brutos de $5,422,348. El firmante certifica que no existen informaciones materiales adversas no divulgadas y atestigua la precisión del aviso.
Precigen, Inc. (PGEN) 양식 144는 Nasdaq에서 252주 보통주의 제안 매도를 시장에 통지하며, 총 시장 가치가 $970이고 발행주식수 297,972,920주에 대응합니다. 제출자는 2018년 7월 3일에 현금 공모로 3,112,507주를 인수했다고 보고합니다.
또한 제출서는 Kapital Joe, LLC (래널드 J. 커크를 대리인으로)이 2025년 9월 18일에 보통주 1,403,360주를 매도하여 총 수익이 $5,422,348에 이른다고 공개합니다. 서명인은 공개되지 않은 중대한 악재 정보가 없으며 고지의 정확성을 선서합니다.
Precigen, Inc. (PGEN) Le Formulaire 144 informe le marché d'une proposition de vente de 252 actions ordinaires sur Nasdaq, d'une valeur marchande agrégée de $970, sur un total de 297 972 920 actions en circulation. Le déclarant indique avoir acquis 3 112 507 actions le 03/07/2018 lors d'une offre publique en espèces.
Le dossier révèle également que Kapital Joe, LLC (Randal J. Kirk comme agent) a vendu 1 403 360 actions ordinaires le 18/09/2025 pour un produit brut de $5 422 348. Le signataire certifie qu'il n'existe pas d'informations importantes non divulguées et atteste de l'exactitude de l'avis.
Precigen, Inc. (PGEN) Formular 144 benachrichtigt den Markt über einen geplanten Verkauf von 252 Stammaktien an der Nasdaq mit einem Gesamthandelswert von $970, gegenüber 297.972.920 ausstehenden Aktien. Der Einreicher meldet, am 03.07.2018 3.112.507 Aktien in einer Barofferte erworben zu haben.
Die Einreichung gibt außerdem bekannt, dass Kapital Joe, LLC (Randal J. Kirk als Bevollmächtigter) am 18.09.2025 1.403.360 Stammaktien verkauft hat und Bruttoerlöse von $5.422.348 erzielt wurden. Der Unterzeichner bestätigt, dass keine unbeachteten wesentlichen nachteiligen Informationen vorliegen und versichert die Richtigkeit des Hinweises.